- Filed
- Feb 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 1.69B sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 1.66B sh |
| Shares Diluted | FY 2025 · Dec 31, 2023 | 1.61B sh |
| Shares Outstanding | FY 2025 · Dec 31, 2025 | 1.76B sh |
| Shares Outstanding | FY 2025 · Dec 31, 2024 | 1.74B sh |
| Shares Outstanding | FY 2025 · Dec 31, 2023 | 1.69B sh |
| Stock Repurchased | FY 2025 · Dec 31, 2025 | $750.87M |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $311.07M |
| Stock Repurchased | FY 2025 · Dec 31, 2023 | $189.39M |
| Capex | FY 2025 · Dec 31, 2025 | $218.98M |
| Capex | FY 2025 · Dec 31, 2024 | $194.83M |
| Capex | FY 2025 · Dec 31, 2023 | $211.73M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $656.17M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $413.48M |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | $246.52M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $3.49B |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $3.61B |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $46.97M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | $36.21M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $1.03B |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $1.05B |
| Cash And Equivalents | FY 2025 · Dec 31, 2023 | $1.78B |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $2.28B |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $2.45B |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $2.41B |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $1.29B |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $1.24B |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $5.4B |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $5.49B |
| Current Assets | FY 2025 · Dec 31, 2025 | $4.58B |
| Current Assets | FY 2025 · Dec 31, 2024 | $4.91B |
| Total Assets | FY 2025 · Dec 31, 2025 | $7.68B |
| Total Assets | FY 2025 · Dec 31, 2024 | $7.94B |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.27 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.42 |
| Eps Diluted | FY 2025 · Dec 31, 2023 | −$0.82 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.27 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.42 |
| Eps Basic | FY 2025 · Dec 31, 2023 | −$0.82 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $979.13M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $919.1M |
| Sga Expense | FY 2025 · Dec 31, 2023 | $857.42M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $1.79B |
| Rd Expense | FY 2025 · Dec 31, 2024 | $1.69B |
| Rd Expense | FY 2025 · Dec 31, 2023 | $1.91B |
| Net Income | FY 2025 · Dec 31, 2025 | −$460.49M |
| Net Income | FY 2025 · Dec 31, 2024 | −$697.86M |
| Net Income | FY 2025 · Dec 31, 2023 | −$1.32B |
| Operating Income | FY 2025 · Dec 31, 2025 | −$532.17M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$787.29M |
| Operating Income | FY 2025 · Dec 31, 2023 | −$1.4B |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $2.67B |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $2.47B |
| Cost Of Revenue | FY 2025 · Dec 31, 2023 | $2.11B |
| Revenue | FY 2025 · Dec 31, 2025 | $5.93B |
| Revenue | FY 2025 · Dec 31, 2024 | $5.36B |
| Revenue | FY 2025 · Dec 31, 2023 | $4.61B |